Tumefactive demyelination—A rare presentation of Anti-MOG Syndrome [PDF]
Annals of Indian Academy of Neurology, 2022 Sesh Sivadasan, Rajalakshmi Poyuran
doaj +2 more sources
Tumefactive Demyelinating Lesion Mimicking Low-Grade Astrocytoma with a T2/FLAIR Mismatch Sign: A Case Report and Review of the Literature [PDF]
DiagnosticsBackground and Clinical Significance: Tumefactive demyelinating lesions (TDLs) are large demyelinating lesions that mimic intracranial tumors, posing a diagnostic challenge in both clinical presentation and conventional imaging.
Maria Karhu +6 more
doaj +2 more sources
Tumefactive demyelination presenting during bevacizumab treatment. [PDF]
BMJ Case Rep, 2015 We report the emergence of tumefactive demyelination during treatment with intravitreal bevacizumab (Avastin). This is of particular significance given that bevacizumab is currently being assessed as a potential treatment option for neuromyelitis optica, another demyelinating condition.
Rice CM +7 more
europepmc +5 more sources
Neuromyelitis Optica Spectrum Disorder with Tumefactive Demyelination mimicking Multiple Sclerosis: a rare case [PDF]
Frontiers in Neurology, 2016 Neuromyelitis optica spectrum disorder (NMOSD) is a diverse condition which not only encompasses isolated longitudinally extensive transverse myelitis and optic neuritis but also includes area postrema syndrome, acute brainstem syndrome, symptomatic ...
UJJAWAL eROY +5 more
doaj +2 more sources
Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States. [PDF]
Eur J Neurol, 2022 Fereidan-Esfahani M +5 more
europepmc +2 more sources
Recurrent tumefactive demyelination: An unusual presentation.
J Pediatr Neurosci, 2015 Tumefactive multiple sclerosis (MS) is a rare variant of MS characterized by the presence of large demyelinating plaques of more than 2 cm, identified with magnetic resonance imaging (MRI). Distinguishing tumefactive lesions from other etiologies of intracranial space occupying lesions is necessary to avoid the inadvertent intervention.
Bhargava A +4 more
europepmc +3 more sources
Recurrent tumefactive demyelinating lesions in an elderly woman
Radiology Case Reports, 2022 Here we describe a 72-year old Caucasian woman who presented with progressive left hemiparesis and hemisensory deficits due to a pathology-confirmed tumefactive demyelinating lesion in the right frontoparietal region.
Erika L. Weil, MD +1 more
doaj +1 more source
Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
Frontiers in Neurology, 2022 Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a neuropathologist is warranted for accurate diagnosis.
Aigli G. Vakrakou +5 more
doaj +1 more source
Tumefactive demyelinating lesion [PDF]
Neurology, 2007 A previously healthy 31-year-old woman presented with a 2-week history of progressive left hemiparesis. MRI (figure) demonstrated a 3 cm enhancing mass in the right posterior frontal white matter with several smaller lesions in …
Mathew R, Guilfoyle, Ramez W, Kirollos
openaire +2 more sources
Frontiers in Neurology, 2023 BackgroundTumefactive demyelinating lesions (TDLs) are defined as lesions >2 cm on MRI of the brain. They are identified in a range of demyelinating diseases including massive demyelination due to Marburg's acute MS, Schilder's Disease, Balo's ...
Thérèse Boyle +11 more
doaj +1 more source